You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML HAM

Showing 1 - 25 of 1,761
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Germany (HAM, LDAC and/or Mitoxantrone)

Completed
  • Acute Myeloid Leukemia
  • HAM
  • LDAC and/or Mitoxantrone
  • Heidelberg, Baden-Wuerttemberg, Germany
  • +17 more
Aug 2, 2022

Relapsed/Refractory Acute Myeloid Leukemia Trial in Worldwide (CPI-613 + High Dose Cytarabine and Mitoxantrone, High Dose

Terminated
  • Relapsed/Refractory Acute Myeloid Leukemia
  • CPI-613 + High Dose Cytarabine and Mitoxantrone
  • +3 more
  • Scottsdale, Arizona
  • +59 more
Jul 26, 2022

Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)

Not yet recruiting
  • Acute Myeloid Leukemia in Children
  • Standard Intervention
  • Investigational Intervention
  • (no location specified)
Aug 8, 2023

AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

Recruiting
  • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
  • MRD-triggered arm
  • Prophylactic Arm
  • Heidelberg, BW, Germany
    University Hospital Heidelberg Med5
Jan 4, 2021

Acute Myeloid Leukemia Trial in Baltimore (Calaspargase pegol-mknl)

Recruiting
  • Acute Myeloid Leukemia
  • Calaspargase pegol-mknl
  • Baltimore, Maryland
    Greenebaum Cancer Center, University of Maryland Medical Systems
Dec 14, 2021

Evaluation of Patients With HAM/TSP

Recruiting
  • HTLV-I Infection
  • Tropical Spastic Paraparesis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    HTLV-I Infection Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Raltegravir)

    Completed
    • HTLV-I Infection
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 18, 2022

    Leukemia, Myeloid, Acute Trial in United States (DFP-10917, Cytarabine, Azacitidine)

    Recruiting
    • Leukemia, Myeloid, Acute
    • Birmingham, Alabama
    • +38 more
    Dec 25, 2021

    Core Binding Factor Acute Myeloid Leukemia, KIT Mutation-Related Tumors Trial in Suzhou (Avapritinib)

    Recruiting
    • Core Binding Factor Acute Myeloid Leukemia
    • KIT Mutation-Related Tumors
    • Suzhou, Jiangsu, China
      First Affiliated Hospital of Soochow University
    Apr 7, 2023

    Voice Biomarkers Predictive of Depression and Anxiety

    Active, not recruiting
    • Depression, Anxiety
    • +2 more
    • Patient Health Questionnaire-9
    • +3 more
    • Berkeley, California
      Kintsugi Mindful Wellness, Inc.
    Aug 16, 2022

    Osteonecrosis Due to Drugs, Jaw Trial in Besançon (Human Amniotic Membrane, Conventional/Standard treatment)

    Active, not recruiting
    • Osteonecrosis Due to Drugs, Jaw
    • Human Amniotic Membrane
    • Conventional/Standard treatment
    • Besançon, France
      CHU de Besancon
    Dec 21, 2022

    AML, Adult Trial (Pharmacoscopy, Clinical standard-of-care (physician's choice))

    Not yet recruiting
    • AML, Adult
    • Pharmacoscopy
    • Clinical standard-of-care (physician's choice)
    • (no location specified)
    Nov 20, 2023

    HAM/TSP Trial run by the NINDS (Teriflunomide)

    Recruiting
    • HAM/TSP
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations Trial in Worldwide (Crenolanib, Cytarabine,

    Recruiting
    • Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
    • Sacramento, California
    • +61 more
    Apr 28, 2021

    iN the Real Practice

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Vyxeos liposomal
    • Roma, Italy
      Policlinico Tor Vergata
    Nov 16, 2023

    AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)

    Not yet recruiting
    • AML, Adult
    • Minimal Residual Disease
    • chidamide and azacitidine
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Sep 27, 2023

    Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

    Active, not recruiting
    • Hematological Malignancies
    • Duarte, California
    • +26 more
    Dec 7, 2022

    AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

    Not yet recruiting
    • AML, Adult
    • Minimal Residual Disease
    • CD33/CLL1 dual CAR-NK cell
    • +5 more
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Aug 4, 2023

    Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 27, 2023

    Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)

    Recruiting
    • Acute Myeloid Leukemia
    • CLL1 and CD38 dual-target CAR-T injection
    • Kunming, Yunnan, China
      920th Hospital of Joint LogisticsSupport Force of People's Liber
    Oct 26, 2023

    AML, MDS Trial in Tianjin (XZB-0004)

    Not yet recruiting
    • AML
    • MDS
    • Tianjin, Tianjin, China
      Hematology Hospital, Chinese Academy of Medical Sciences
    Feb 13, 2023

    Depression Trial in Fortaleza (Escitalopram 10mg, LABCAT TCJUSS, LABCAT TCJUSS Placebo)

    Terminated
    • Depression
    • Escitalopram 10mg
    • +3 more
    • Fortaleza, Ceará, Brazil
      Unidade de Farmacologia Clínica (UNIFAC - Universidade Federal d
    Jun 13, 2022

    Acute Myeloid Leukemia Trial in Beijing, Shenzhen, Haikou (CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells)

    Recruiting
    • Acute Myeloid Leukemia
    • CLL-1, CD33, CD38 and/or CD123-specific universal CAR- T cells
    • Beijing, Beijing, China
    • +2 more
    Aug 8, 2023

    Leukemia, Myeloid, Acute Trial in Worldwide (CC-90009, Venetoclax, Azacitidine)

    Recruiting
    • Leukemia, Myeloid, Acute
    • San Francisco, California
    • +25 more
    Jan 9, 2023

    Myeloid Leukemia, MDS Trial (IFN-?)

    Not yet recruiting
    • Myeloid Leukemia
    • Myelodysplastic Syndromes
    • (no location specified)
    Nov 15, 2023